通过蛋白激酶D对奥普丁尿素的酸化调节了帕金基基因依赖性线粒细胞吸收
Robert Weil1, Emmanuel Laplantine1, Messaouda Attailia2
1Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Sorbonne Université UMRS CR7 - Inserm U1135 - CNRS EMR8255, Faculté de Santé, 91 Boulevard de l'Hôpital, F-75013 Paris, France.
蛋白激酶D (PKD) 调节了线粒体,即破坏的线粒体的降解过程. 抑制PKD通过促进OPTINEURIN-PARKIN复合体的形成来增强 mitofgy,帮助细胞对氧化应激的反应.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 线粒体细胞衰变对于线粒体质量控制和预防神经退行至关重要.
- PINK1/帕金通路是线粒的主要机制,利用像Optineurin (Optn) 这样的受体.
研究的目的:
- 为了研究蛋白激酶D (PKD) 在依赖光氨尿素的线粒细胞衰变中的作用.
- 阐明PKD影响线粒和帕金活动的机制.
主要方法:
- 评估PKD对受损线粒体的激活和招募.
- 通过PKD分析OPTINEURIN的酸化.
- 评估PKD抑制对Optineurin-LC3相互作用和Parkins招募的影响.
- 测量线粒体的活性氧物种 (ROS) 生产和线粒体质量.
主要成果:
- PKD被激活并被招募到受损的线粒体中.
- PKD酸化了奥普丁尿素,增强了它与帕金和帕金的结合酶活性的相互作用.
- 抑制PKD出乎意料地增强了OPTINEURIN-LC3相互作用,帕金斯招募和整体线粒细胞衰变.
- 增强的线粒体与线粒体ROS增加和线粒体质量减少有关.
结论:
- PKD作为依赖氨酸的线粒细胞衰变的调节剂.
- PKD信号影响了帕金介导的线粒体降解的效率.
- 调节PKD活动可能提供一种策略,以增强细胞防御氧化应激诱导的损伤.
更多相关视频
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of the Unfolded Protein Response
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
